Court rejects Cutis Biotech plea against Serum Institute claiming its trademark Covishield ...Middle East

Devdiscourse - Opinion
Court rejects Cutis Biotech plea against Serum Institute claiming its trademark Covishield
A civil court in Pune rejected the injunction application filed on behalf of CUTIS Biotech against Serum Institute of India (SII), claiming trademark "Covishield" of the Covid-19 vaccine, on Saturday. According to SII's press release, earlier this month, Cutis-Biotech, a pharmaceutical products manufacturer and seller based in Maharashtra, filed a suit in the civil court seeking to restrain SII from using the trademark Covishield or any other similar names for its COVID-19 vaccine and claimed the pharma firm is a prior user of the brand name.

Hence then, the article about court rejects cutis biotech plea against serum institute claiming its trademark covishield was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Court rejects Cutis Biotech plea against Serum Institute claiming its trademark Covishield )

Apple Storegoogle play

Last updated :

Also on site :